Angitia
Biotechnology company developing gene therapies for cardiovascular diseases.
Location
United Kingdom
Categories
biotech, cardiovascular, gene-therapy, therapeutics
Notes
Angitia is a biotechnology company in the Bain Capital Life Sciences portfolio focused on developing innovative therapeutics for cardiovascular diseases. The company is working on gene therapy approaches to address serious cardiovascular conditions.
Team
- Leadership team information not publicly available
Additional Research Findings
- In Bain Capital Life Sciences portfolio
- Focus on cardiovascular disease therapeutics
- Gene therapy development platform